Impaired contractile recovery after low-flow myocardial ischemia in a porcine model of metabolic syndrome.

Clinical metabolic syndrome conveys a poor prognosis in patients with acute coronary syndrome, not fully accounted for by the extent of coronary atherosclerosis. To explain this observation, we determined whether postischemic myocardial contractile and metabolic function are impaired in a porcine dietary model of metabolic syndrome without atherosclerosis. Micropigs (n = 28) were assigned to a control diet (low fat, no added sugars) or an intervention diet (high saturated fat and simple sugars, no added cholesterol) for 7 mo. The intervention diet produced obesity, hypertension, dyslipidemia, and impaired glucose tolerance, but not atherosclerosis. Under open-chest, anesthetized conditions, pigs underwent 45 min of low-flow myocardial ischemia and 120 min of reperfusion. In both diet groups, contractile function was similar at baseline and declined similarly during ischemia. However, after 120 min of reperfusion, regional work recovered to 21 ± 12% of baseline in metabolic syndrome pigs compared with 61 ± 13% in control pigs (P = 0.01). Ischemia-reperfusion caused a progressive decline in mechanical/metabolic efficiency (regional work/O2 consumption) in metabolic syndrome hearts, but not in control hearts. Metabolic syndrome hearts demonstrated altered fatty acyl composition of cardiolipin and increased Akt phosphorylation in both ischemic and nonischemic regions, suggesting tonic activation. Metabolic syndrome hearts used more fatty acid than control hearts (P = 0.03). When fatty acid availability was restricted by prior insulin exposure, differences between groups in postischemic contractile recovery and mechanical/metabolic efficiency were eliminated. In conclusion, pigs with characteristics of metabolic syndrome demonstrate impaired contractile and metabolic recovery after low-flow myocardial ischemia. Contributory mechanisms may include remodeling of cardiolipin, abnormal activation of Akt, and excessive utilization of fatty acid substrates.

[1]  Thomas A. Burgess,et al.  Overfed Ossabaw swine with early stage metabolic syndrome have normal coronary collateral development in response to chronic ischemia , 2012, Basic Research in Cardiology.

[2]  R. Schwenk,et al.  High fat diet induced diabetic cardiomyopathy. , 2011, Prostaglandins, leukotrienes, and essential fatty acids.

[3]  G. Liguori,et al.  Persistent Increase of Prevalence of Metabolic Syndrome Among U.S. Adults: NHANES III to NHANES 1999–2006 , 2010, Diabetes Care.

[4]  Lawrence Joseph,et al.  The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.

[5]  T. Ploug,et al.  Cardiac and metabolic changes in long-term high fructose-fat fed rats with severe obesity and extensive intramyocardial lipid accumulation. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[6]  B. Bergman,et al.  Multiple abnormalities of myocardial insulin signaling in a porcine model of diet-induced obesity. , 2010, American journal of physiology. Heart and circulatory physiology.

[7]  G. Heusch,et al.  Loss of cardioprotection with ageing. , 2009, Cardiovascular research.

[8]  B. Bergman,et al.  Myocardial glucose and lactate metabolism during rest and atrial pacing in humans , 2009, The Journal of physiology.

[9]  N. Secher,et al.  Blood Lactate is an Important Energy Source for the Human Brain , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  G. Heusch,et al.  Ischemic Postconditioning in Pigs: No Causal Role for Risk Activation , 2008, Circulation research.

[11]  C. Fang,et al.  Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription. , 2008, American journal of physiology. Heart and circulatory physiology.

[12]  D. Faxon,et al.  Long-term outcomes in non-diabetic patients with metabolic syndrome undergoing revascularization for multi-vessel coronary artery disease. , 2008, Atherosclerosis.

[13]  R. Witteles,et al.  Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. , 2008, Journal of the American College of Cardiology.

[14]  Y. van der Graaf,et al.  Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. , 2007, European heart journal.

[15]  P. Legrand,et al.  Myristic acid increases the activity of dihydroceramide Delta4-desaturase 1 through its N-terminal myristoylation. , 2007, Biochimie.

[16]  D. Ouwens,et al.  Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification , 2007, Diabetologia.

[17]  R. Murphy,et al.  Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure Published, JLR Papers in Press, April 10, 2007. , 2007, Journal of Lipid Research.

[18]  D. Yellon,et al.  Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection , 2007, Heart Failure Reviews.

[19]  G. Massicotte,et al.  The rapid onset of hyperglycaemia in ZDF rats was associated with a widespread alteration of metabolic proteins implicated in glucose metabolism in the heart. , 2006, Canadian journal of physiology and pharmacology.

[20]  Sanjoy Ghosh,et al.  Cardiac cell death in early diabetes and its modulation by dietary fatty acids. , 2006, Biochimica et biophysica acta.

[21]  H. Yoshimatsu,et al.  Pioglitazone but Not Glibenclamide Improves Cardiac Expression of Heat Shock Protein 72 and Tolerance Against Ischemia/Reperfusion Injury in the Heredity Insulin-Resistant Rat , 2006, Diabetes.

[22]  E. Falk,et al.  Size of myocardial infarction induced by ischaemia/reperfusion is unaltered in rats with metabolic syndrome. , 2006, Clinical science.

[23]  C. Long,et al.  The PPAR-alpha activator fenofibrate fails to provide myocardial protection in ischemia and reperfusion in pigs. , 2006, American journal of physiology. Heart and circulatory physiology.

[24]  P. Faure,et al.  Fructose-Fed Rat Hearts are Protected Against Ischemia-Reperfusion Injury , 2006, Experimental biology and medicine.

[25]  M. Alloosh,et al.  Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. , 2006, Comparative medicine.

[26]  R. Cooksey,et al.  Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. , 2005, Endocrinology.

[27]  H. Drexel,et al.  The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients. , 2005, The Journal of clinical endocrinology and metabolism.

[28]  Graciela Cárdenas,et al.  Isolated heart function during ischemia and reperfusion in sucrose-fed rats: effect of insulin infusion. , 2005, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[29]  D. Kass,et al.  PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. , 2005, The Journal of clinical investigation.

[30]  L. Tavazzi,et al.  Metabolic syndrome and risk of cardiovascular events after myocardial infarction. , 2005, Journal of the American College of Cardiology.

[31]  R. Murphy,et al.  Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.M500031-JLR200 , 2005, Journal of Lipid Research.

[32]  S. Tanguy,et al.  Early pre-diabetic state alters adaptation of myocardial glucose metabolism during ischemia in rats , 2005, Molecular and Cellular Biochemistry.

[33]  M. Birnbaum,et al.  AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. , 2004, The Journal of clinical investigation.

[34]  J. Chatham,et al.  Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. , 2004, American journal of physiology. Endocrinology and metabolism.

[35]  R. Capaldi,et al.  Immunocapture and microplate-based activity measurement of mammalian pyruvate dehydrogenase complex. , 2003, Analytical biochemistry.

[36]  S. Cook,et al.  Phenotypic Spectrum Caused by Transgenic Overexpression of Activated Akt in the Heart* , 2002, The Journal of Biological Chemistry.

[37]  Peter L McLennan,et al.  Cardiac Membrane Fatty Acid Composition Modulates Myocardial Oxygen Consumption and Postischemic Recovery of Contractile Function , 2002, Circulation.

[38]  K. Clarke,et al.  Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart. , 2002, Diabetes.

[39]  J. Vanoverschelde,et al.  Glucose for the heart. , 1999, Circulation.

[40]  J. Russell,et al.  Postischemic cardiac performance in the insulin-resistant JCR:LA-cp rat. , 1997, The American journal of physiology.

[41]  J. Balschi,et al.  1H NMR measurement of triacylglycerol accumulation in the post-ischemic canine heart after transient increase of plasma lipids. , 1997, Journal of molecular and cellular cardiology.

[42]  C. Greyson,et al.  Low-dose inotropic stimulation during left ventricular ischaemia does not worsen post-ischaemic dysfunction. , 1996, Cardiovascular research.

[43]  R. Wilson,et al.  Metabolic and hemodynamic effects of a graded intracoronary insulin infusion in normal and fat anesthetized dogs: a preliminary study. , 1996, Hypertension.

[44]  C. Greim,et al.  Assessment of changes in left ventricular wall stress from the end-systolic pressure-area product. , 1995, British journal of anaesthesia.

[45]  M. Holness,et al.  The pyruvate dehydrogenase complex: nutrient control and the pathogenesis of insulin resistance. , 1995, The Journal of nutrition.

[46]  E. Lewandowski,et al.  Pyruvate dehydrogenase influences postischemic heart function. , 1995, Circulation.

[47]  R. Reneman,et al.  Fatty acid homeostasis in the normoxic and ischemic heart. , 1992, Physiological reviews.

[48]  L. Opie,et al.  Protons in ischemia: where do they come from; where do they go to? , 1991, Journal of molecular and cellular cardiology.

[49]  J. Thornby,et al.  Postischemic myocardial "stunning". Identification of major differences between the open-chest and the conscious dog and evaluation of the oxygen radical hypothesis in the conscious dog. , 1991, Circulation research.

[50]  H. Gewirtz,et al.  Origin of anterior interventricular vein blood in domestic swine. , 1991, The American journal of physiology.

[51]  G. Heusch,et al.  Myocardial lactate release during ischemia in swine. Relation to regional blood flow. , 1990, Circulation.

[52]  A. Liedtke,et al.  Effects of the fatty acid blocking agents, oxfenicine and 4-bromocrotonic acid, on performance in aerobic and ischemic myocardium. , 1987, Journal of molecular and cellular cardiology.

[53]  G. Cooney,et al.  The activity of the pyruvate dehydrogenase complex in heart and liver from mice during the development of obesity and insulin resistance. , 1987, The Biochemical journal.

[54]  A. Liedtke,et al.  Effects of Excess Free Fatty Acids on Mechanical and Metabolic Function in Normal and Ischemic Myocardium in Swine , 1978, Circulation research.

[55]  C. Hoppel,et al.  Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. , 1977, The Journal of biological chemistry.

[56]  B CHANCE,et al.  Respiratory enzymes in oxidative phosphorylation. I. Kinetics of oxygen utilization. , 1955, The Journal of biological chemistry.

[57]  B CHANCE,et al.  Respiratory enzymes in oxidative phosphorylation. II. Difference spectra. , 1955, The Journal of biological chemistry.

[58]  G. Sparagna,et al.  Role of cardiolipin alterations in mitochondrial dysfunction and disease. , 2007, American journal of physiology. Cell physiology.

[59]  X. Leverve,et al.  High dietary sucrose triggers hyperinsulinemia, increases myocardial β-oxidation, reduces glycolytic flux and delays post-ischemic contractile recovery , 2006, Molecular and Cellular Biochemistry.

[60]  S. Summers,et al.  Ceramides in insulin resistance and lipotoxicity. , 2006, Progress in lipid research.

[61]  T. L. Pinto,et al.  Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. , 2006, Cardiovascular revascularization medicine : including molecular interventions.

[62]  M A Tries,et al.  Stable labeled microspheres to measure perfusion: validation of a neutron activation assay technique. , 2001, American Journal of Physiology. Heart and Circulatory Physiology.

[63]  S. Innis,et al.  Dynamic modulation of mitochondrial inner-membrane lipids in rat heart by dietary fat. , 1981, The Biochemical journal.